BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17586475)

  • 1. Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.
    Hamadmad SN; Hohl RJ
    Biochem Pharmacol; 2007 Aug; 74(4):590-600. PubMed ID: 17586475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin receptor signal transduction requires protein geranylgeranylation.
    Hamadmad SN; Henry MK; Hohl RJ
    J Pharmacol Exp Ther; 2006 Jan; 316(1):403-9. PubMed ID: 16203826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
    Feldman L; Wang Y; Rhim JS; Bhattacharya N; Loda M; Sytkowski AJ
    Prostate; 2006 Feb; 66(2):135-45. PubMed ID: 16161153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total saponins of Panax ginseng (TSPG) promote erythroid differentiation of human CD34+ cells via EpoR-mediated JAK2/STAT5 signaling pathway.
    Chen D; Zuo G; Li C; Hu X; Guan T; Jiang R; Li J; Lin X; Li F; Luo C; Wang H; Lei C; Long X; Wang Y; Wang J
    J Ethnopharmacol; 2009 Nov; 126(2):215-20. PubMed ID: 19735711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
    Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
    Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
    Um M; Gross AW; Lodish HF
    Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment.
    Xie Z; Chen F; Wu X; Zhuang C; Zhu J; Wang J; Ji H; Wang Y; Hua X
    Curr Eye Res; 2012 Feb; 37(2):138-44. PubMed ID: 22251399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):99-110. PubMed ID: 9221829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition.
    García-Román N; Alvarez AM; Toro MJ; Montes A; Lorenzo MJ
    Mol Cell Neurosci; 2001 Feb; 17(2):329-41. PubMed ID: 11178870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
    Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
    Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin is neuroprotective on GABAergic neurons against kainic acid-excitotoxicity in the rat spinal cell cultures.
    Won YJ; Yoo JY; Lee JH; Hwang SJ; Kim D; Hong HN
    Brain Res; 2007 Jun; 1154():31-9. PubMed ID: 17493599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin.
    Yin D; Kawabata H; Tcherniamtchouk O; Huynh T; Black KL; Koeffler HP
    Int J Oncol; 2007 Nov; 31(5):1193-8. PubMed ID: 17912447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of erythropoietin on Leydig cell is associated with the activation of Stat5 pathway.
    Yamazaki T; Kanzaki M; Kamidono S; Fujisawa M
    Mol Cell Endocrinol; 2004 Jan; 213(2):193-8. PubMed ID: 15062567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of expression of the human erythropoietin receptor gene.
    Winter SS; Howard T; Ware RE
    Blood Cells Mol Dis; 1996; 22(3):214-24; discussion 224a. PubMed ID: 9075572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells.
    Xia Z; Tan MM; Wong WW; Dimitroulakos J; Minden MD; Penn LZ
    Leukemia; 2001 Sep; 15(9):1398-407. PubMed ID: 11516100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment.
    Xie Z; Wu X; Qiu Q; Gong Y; Song Y; Gu Q; Li C
    Curr Eye Res; 2007 Sep; 32(9):757-64. PubMed ID: 17882708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoprenoid regulation of cell growth: identification of mevalonate-labelled compounds inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate.
    Wejde J; Carlberg M; Hjertman M; Larsson O
    J Cell Physiol; 1993 Jun; 155(3):539-48. PubMed ID: 8491791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein geranylgeranylation is critical for the regulation of survival and proliferation of lymphoma tumor cells.
    van de Donk NW; Schotte D; Kamphuis MM; van Marion AM; van Kessel B; Bloem AC; Lokhorst HM
    Clin Cancer Res; 2003 Nov; 9(15):5735-48. PubMed ID: 14654559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine, a natural cholesterol reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway.
    Issat T; Jakóbisiak M; Golab J
    Oncol Rep; 2006 Dec; 16(6):1273-6. PubMed ID: 17089049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.